Jun Yin

Q: What is Jun Yin email address?

Email Jun Yin at yin_jun@lilly.com. This email is the most updated Jun Yin email found in 2026.

Q: How to contact Jun Yin?

To contact Jun Yin send an email to yin_jun@lilly.com. If you want to call Jun Yin try calling on +13522266574. (updated on November 04, 2024)

Senior Scientific Lead at Eli Lilly and Company | Chandler, Arizona, United States

About Jun Yin

Jun Yin currently serves as a Principal Computational Biologist and Team Lead at Eli Lilly and Company, where he spearheads innovative research in Patient-Centered Oncology Translational Research. His primary focus lies in biomarker discovery, which is crucial for advancing cancer prognosis, diagnosis, and understanding drug resistance mechanisms. With a robust educational foundation that includes a Ph.D. in Chemical Engineering and a minor in statistics, Jun seamlessly integrates engineering principles with cancer biology, enabling him to tackle complex challenges in oncology research.

At Eli Lilly, Jun leads multidisciplinary teams that leverage cutting-edge computational tools and methodologies to analyze large datasets, facilitating the identification of novel biomarkers that can significantly enhance patient outcomes. His expertise in oncology clinical research, combined with proficiency in tools such as MATLAB and flow cytometry, allows him to design and execute sophisticated experiments that elucidate the underlying mechanisms of cancer biology. Jun’s work not only contributes to the development of targeted therapies but also plays a pivotal role in personalizing treatment strategies for patients, thereby aligning with the company’s commitment to patient-centered care.

Key projects under Jun's leadership include collaborations with cross-functional teams to integrate computational models with experimental data, enhancing the predictive power of biomarker assays. His ability to navigate the intersection of biomedical engineering and oncology positions him as a thought leader in the field, driving forward the mission of Eli Lilly to innovate and improve cancer treatment paradigms. Through his dedication to research and his multidisciplinary approach, Jun Yin is making significant strides in the quest for effective cancer therapies that are tailored to individual patient needs.

Jun Yin Work